Mariann Bombicz
Overview
Explore the profile of Mariann Bombicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szilagyi A, Takacs B, Szekeres R, Tarjanyi V, Nagy D, Priksz D, et al.
Geroscience
. 2025 Feb;
PMID: 39966251
No abstract available.
2.
Szekeres R, Priksz D, Bombicz M, Pelles-Tasko B, Szilagyi A, Bernat B, et al.
Aging Dis
. 2024 Nov;
PMID: 39571159
Although age-related deterioration of the cardiac function is a well-studied area of research, the interventions and their molecular pathways have not yet been fully identified. Since physical activity is a...
3.
Pelles-Tasko B, Szekeres R, Takacs B, Szilagyi A, Ujvarosy D, Bombicz M, et al.
Life (Basel)
. 2024 Sep;
14(9).
PMID: 39337931
Retinal ischemia-reperfusion (I/R) injury is a critical pathogenic mechanism in various eye diseases, and an effective therapeutic strategy remains unresolved. Natural derivatives have recently reemerged; therefore, in our present study,...
4.
Szilagyi A, Takacs B, Szekeres R, Tarjanyi V, Nagy D, Priksz D, et al.
Geroscience
. 2024 May;
46(5):4707-4728.
PMID: 38795184
Aging is accompanied by an increased prevalence of degenerative conditions, including those affecting ocular health, which significantly impact quality of life and increase the burden on healthcare systems. Among these,...
5.
Tarjanyi V, Menes A, Hamid L, Kurucz A, Priksz D, Varga B, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542266
Numerous studies have indicated a link between vaccines and the exacerbation of autoimmune diseases including rheumatoid arthritis (RA). However, there is no consensus in clinical practice regarding the optimal timing...
6.
Takacs B, Szilagyi A, Priksz D, Bombicz M, Szabo A, Pelles-Tasko B, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540250
Retinal vascular diseases and consequential metabolic disturbances in the eye are major concerns for healthcare systems all around the world. BGP-15, a drug candidate small-molecule [O-(3-piperidino-2-hydroxy-1-propyl) nicotinic amidoxime dihydrochloride], has...
7.
Therapeutic Aspects of Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction
Szekeres R, Priksz D, Kiss R, Romanescu D, Bombicz M, Varga B, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686067
This study evaluates the potential therapeutic effects of anthocyanin-rich (sour cherry) extract (PCE) on atherosclerosis-associated cardiac dysfunction, described by the impairment of the NO-PKG (nitric oxide-protein kinase G) pathway and...
8.
Bernat B, Erdelyi R, Fazekas L, Garami G, Szekeres R, Takacs B, et al.
Pharmaceuticals (Basel)
. 2023 Mar;
16(3).
PMID: 36986459
Multi-target drug candidate BGP-15 has shown cardioprotective and antiarrhythmic actions in diseased models. Here, we investigated the effects of BGP-15 on ECG and echocardiographic parameters, heart rate variability (HRV), and...
9.
Blaga Z, Czine P, Takacs B, Szilagyi A, Szekeres R, Wachal Z, et al.
Int J Environ Res Public Health
. 2023 Jan;
20(2).
PMID: 36674026
The COVID-19 pandemic has posed a huge challenge to the world in recent years. The development of vaccines that are as effective as possible and accessible to society offers a...
10.
Wachal Z, Szilagyi A, Takacs B, Szabo A, Priksz D, Bombicz M, et al.
Front Pharmacol
. 2022 Oct;
13:1034389.
PMID: 36188608
[This corrects the article DOI: 10.3389/fphar.2021.650207.].